Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.06
1% from low
Exchange
OTC Link
CS
NOVO INTEGRATED SCIENCES
No one on the platform currently holds NVOS.
No tracked institution reports a position in NVOS as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-11-07 | 1-for-10reverse |
| 2021-02-01 | 1-for-10reverse |
No one on the platform has traded NVOS yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ENTX With Positive FDA Feedback on Phase 3, Entera Bio Just Got the Answer the Market Was Waiting For >> https://www.benzinga.com/content/60014792/positive-fda-feedback-phase-3-entera-bio-just-got-answer-market-was-waiting $LLY $NVOS $SEPN
View on StockTwits ↗$ENTX Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis https://www.globenewswire.com/news-release/2026/06/22/3315282/0/en/entera-bio-receives-positive-fda-feedback-on-12-month-registrational-phase-3-study-for-eb613-the-first-oral-anabolic-tablet-in-development-for-postmenopausal-women-with-osteoporosi.html $LLY $SEPN $NVOS
View on StockTwits ↗#NOVONORDISK ✅ Alleged major cybersecurity breach reported at Novo Nordisk ✅ Hackers claim to have stolen nearly 1TB of sensitive company data ✅ Cybercriminal group alleges the breach occurred after a $25 million ransom demand was rejected ✅ The stolen data is reportedly being threatened for public release ✅ Incident raises concerns over data security, operational risks, and potential regulatory implications 🚨 Investors will closely monitor the company's response and any impact on business operations. $NVOS
View on StockTwits ↗$NVOS I was looking for $NVO and I found this ... thing 😁 What is their business? Do I have to buy the whole company? 😅
View on StockTwits ↗$NVOS if this breaks resistance it could move FAST
View on StockTwits ↗I'm back, and fully recovered, thanks to massive profits from $SMMT and $NEOV, countered the clusterfuck that was $NVOS and their scumbag CEO. I have a banger, $KARX Legit fundamentals, already moving up, volume is picking up. Should be $1.50-$2.00 on actual fundamentals when their numbers come out in the next week or so. Get it now or don't come crying to me that you didn't.
View on StockTwits ↗Novo Nordisk ✅ Sets aggressive pricing strategy in India ✅ Starting dose of Ozempic & Wegovy priced at just ₹202/day ✅ Major step toward expanding obesity & diabetes treatment access ✅ Signals strong intent to capture India’s fast-growing GLP-1 market ✅ Could disrupt pricing dynamics in the domestic pharma space $NVOS
View on StockTwits ↗$VKTX with $NVOS trying to find something better, im surprised Viking is getting bypassed by all these BP for a partnership or BO. Novo just partnered with Vivtex with up to 2bil to find and scale obesity & diabetes. Unless Viking is asking foe too much, waiting on that positive PH3 will be the only thing to moon the stock.
View on StockTwits ↗$HIMS $NVOS Lot more downside https://www.cnbc.com/amp/2026/02/07/hims-hers-weight-loss-pill.html
View on StockTwits ↗$NVOS This damn thing being 12% up today is a slap in the face lol
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.